Kato-Hayashi H - Search Results

1

Pharmaceutical intervention for adverse events improves quality of life in patients with cancer undergoing outpatient chemotherapy.

Fujii H, Ueda Y, Hirose C, Ohata K, Sekiya K, Kitahora M, Sadaka S, Yamamoto S, Watanabe D, Kato-Hayashi H, Iihara H, Kobayashi R, Kaburaki M, Matsuhashi N, Takahashi T, Makiyama A, Yoshida K, Hayashi H, Suzuki A. Fujii H, et al. Among authors: kato hayashi h. J Pharm Health Care Sci. 2022 Mar 2;8(1):8. doi: 10.1186/s40780-022-00239-w. J Pharm Health Care Sci. 2022. PMID: 35236407 Free PMC article.

2

Real-world data of the association between quality of life using the EuroQol 5 Dimension 5 Level utility value and adverse events for outpatient cancer chemotherapy.

Hirose C, Fujii H, Iihara H, Ishihara M, Nawa-Nishigaki M, Kato-Hayashi H, Ohata K, Sekiya K, Kitahora M, Matsuhashi N, Takahashi T, Okuda K, Naruse M, Ishihara T, Sugiyama T, Yoshida K, Suzuki A. Hirose C, et al. Among authors: kato hayashi h. Support Care Cancer. 2020 Dec;28(12):5943-5952. doi: 10.1007/s00520-020-05443-8. Epub 2020 Apr 12. Support Care Cancer. 2020. PMID: 32281034 Free PMC article.

3

Anorexia, pain and peripheral neuropathy are associated with a decrease in quality of life in patients with advanced pancreatic cancer receiving outpatient chemotherapy - a retrospective observational study.

Fujii H, Koda M, Sadaka S, Ohata K, Kato-Hayashi H, Iihara H, Kobayashi R, Ishihara T, Uemura S, Iwashita T, Hayashi H, Sugiyama T, Shimizu M, Suzuki A. Fujii H, et al. Among authors: kato hayashi h. J Pharm Health Care Sci. 2021 Aug 2;7(1):27. doi: 10.1186/s40780-021-00210-1. J Pharm Health Care Sci. 2021. PMID: 34334136 Free PMC article.

4

Severe Neutropenia is Associated with Better Clinical Outcomes in Patients with Advanced Pancreatic Cancer Who Receive Modified FOLFIRINOX Therapy.

Yamada Y, Fujii H, Watanabe D, Kato-Hayashi H, Ohata K, Kobayashi R, Ishihara T, Uemura S, Iwashita T, Shimizu M, Suzuki A. Yamada Y, et al. Cancers (Basel). 2018 Nov 16;10(11):454. doi: 10.3390/cancers10110454. Cancers (Basel). 2018. PMID: 30453583 Free PMC article.

5

High total bilirubin level is a significant risk factor for severe neutropenia in patients receiving irinotecan-based chemotherapy.

Yamada Y, Fujii H, Ohata K, Kato-Hayashi H, Watanabe D, Ishihara T, Uemura S, Iwashita T, Imai H, Matsuhashi N, Takahashi T, Sugiyama T, Shimizu M, Yoshida K, Suzuki A. Yamada Y, et al. Med Oncol. 2019 Jun 3;36(7):63. doi: 10.1007/s12032-019-1288-7. Med Oncol. 2019. PMID: 31161433

6

Comparison of Chemotherapy-induced Nausea and Vomiting Between Gemcitabine Plus Nab-paclitaxel Combination Chemotherapy and Gemcitabine Monotherapy in Patients With Advanced Pancreatic Cancer.

Ohata K, Fujii H, Sadaka S, Kato-Hayashi H, Iihara H, Kobayashi R, Uemura S, Iwashita T, Shimizu M, Suzuki A. Ohata K, et al. Among authors: kato hayashi h. Anticancer Res. 2021 Jul;41(7):3643-3648. doi: 10.21873/anticanres.15154. Anticancer Res. 2021. PMID: 34230162

7

Control and Risk Factors of Nausea and Vomiting in Patients With Cervical Cancer Receiving Radiotherapy.

Uno A, Yamamoto S, Iihara H, Fujii H, Makita C, Hayasaki Y, Ueda Y, Ito M, Takenaka M, Kumano T, Mori M, Yasue M, Kato-Hayashi H, Kobayashi R, Morishige KI, Matsuo M, Hayashi H, Suzuki A. Uno A, et al. Among authors: kato hayashi h. Anticancer Res. 2022 Jun;42(6):3117-3123. doi: 10.21873/anticanres.15800. Anticancer Res. 2022. PMID: 35641271

8

Impact of First-Line FOLFIRINOX-Induced Peripheral Neuropathy on the Efficacy of Second-Line GnP in Patients with Unresectable Advanced Pancreatic Cancer.

Sadaka S, Iwashita T, Fujii H, Kato-Hayashi H, Ohata K, Uemura S, Shimizu M, Suzuki A. Sadaka S, et al. Among authors: kato hayashi h. J Clin Med. 2022 Oct 6;11(19):5895. doi: 10.3390/jcm11195895. J Clin Med. 2022. PMID: 36233762 Free PMC article.

9

Gastrointestinal bleeding associated with chronic excessive use overdosing with topical ketoprofen patch in elderly patient.

Hirose S, Matsuura K, Kato-Hayashi H, Suzuki A, Ohata K, Kobayashi R, Ibuka T, Araki H, Shimizu M, Itoh Y. Hirose S, et al. Scand J Gastroenterol. 2018 Jan;53(1):120-123. doi: 10.1080/00365521.2017.1390602. Epub 2017 Oct 18. Scand J Gastroenterol. 2018. PMID: 29043859

10

Implementation of a standardised pharmacist check of medical orders prior to preparation of anticancer drugs to reduce drug wastage.

Yamada H, Kobayashi R, Shimizu S, Yamada Y, Ishida M, Shimoda H, Kato-Hayashi H, Fujii H, Iihara H, Tanaka H, Suzuki A. Yamada H, et al. Among authors: kato hayashi h. Int J Clin Pract. 2020 Apr;74(4):e13464. doi: 10.1111/ijcp.13464. Epub 2019 Dec 19. Int J Clin Pract. 2020. PMID: 31830345

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters